Prognostic value of cardiac troponins in patients with acute coronary disease.
Morais
J
J
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017985:Dalteparin / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D008297:Male; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism; D011379:Prognosis; D011446:Prospective Studies; D000077466:Tirofiban; D019210:Troponin I / Q000032:analysis*; D014443:Tyrosine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D019210:Troponin I; D014443:Tyrosine; D000077466:Tirofiban; D017985:Dalteparin; D000077284:Abciximab